Koenig Scott Insider Trades

Insider Trading History

Track insider trading activity for Koenig Scott. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Macrogenics
Macrogenics MGNX
Director
Holding Value $94.4k 22,000 shares
Last Trade
May 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$116k 25,750 shares
$4.52
$4.29
Macrogenics
Macrogenics MGNX
Director
Holding Value $3.72M 867,240 shares
Last Trade
Feb 15, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$36.2k 21,165 shares
$1.71
$4.29
Macrogenics
Macrogenics MGNX
Director
Holding Value $0 0 shares
Last Trade
Feb 15, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$36.2k 21,165 shares
$1.71
$4.29
Macrogenics
Macrogenics MGNX
Director
Holding Value $3.63M 846,075 shares
Last Trade
Feb 08, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28.7k 15,831 shares
$1.81
$4.29
Macrogenics
Macrogenics MGNX
Director
Holding Value $67.9k 15,832 shares
Last Trade
Feb 08, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$28.7k 15,831 shares
$1.81
$4.29
Macrogenics
Macrogenics MGNX
President And CEO
Holding Value $182k 42,330 shares
Last Trade
Feb 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$108k 42,329 shares
$2.56
$4.29
Macrogenics
Macrogenics MGNX
President And CEO
Holding Value $3.34M 777,415 shares
Last Trade
Feb 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$108k 42,329 shares
$2.56
$4.29
Macrogenics
Macrogenics MGNX
President And CEO
Holding Value $3.15M 735,086 shares
Last Trade
Feb 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$82.3k 31,673 shares
$2.60
$4.29
Macrogenics
Macrogenics MGNX
President And CEO
Holding Value $272k 63,327 shares
Last Trade
Feb 08, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$82.3k 31,673 shares
$2.60
$4.29
Macrogenics
Macrogenics MGNX
President And CEO
Holding Value $1.83M 427,480 shares
Last Trade
Oct 07, 2024 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$191k 53,265 shares
$3.59
$4.29
Macrogenics
Macrogenics MGNX
President And CEO
Holding Value $0 0 shares
Last Trade
Oct 07, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$191k 53,265 shares
$3.59
$4.29
Macrogenics
Macrogenics MGNX
President And CEO
Holding Value $1.61M 374,215 shares
Last Trade
Sep 23, 2024 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$1.15M 374,215 shares
$3.06
$4.29
Macrogenics
Macrogenics MGNX
President And CEO
Holding Value $3.02M 703,413 shares
Last Trade
Sep 23, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$1.15M 374,215 shares
$3.06
$4.29
GlycoMimetics
GlycoMimetics GLYC
Director
Holding Value $628k 40,000 shares
Last Trade
May 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.48M 40,000 shares
$162.00
$15.70
Catalyst Biosciences
Catalyst Biosciences CBIO
Director
Holding Value $612k 40,000 shares
Last Trade
May 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.5k 40,000 shares
$0.51
$15.30
Macrogenics
Macrogenics MGNX
President And CEO
Holding Value $363k 84,659 shares
Last Trade
Feb 15, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$737k 42,341 shares
$17.40
$4.29
Macrogenics
Macrogenics MGNX
President And CEO
Holding Value $4.62M 1,077,628 shares
Last Trade
Feb 15, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$250k 14,349 shares
$17.40
$4.29
Macrogenics
Macrogenics MGNX
President And CEO
Holding Value $4.68M 1,091,977 shares
Last Trade
Feb 15, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$737k 42,341 shares
$17.40
$4.29
Macrogenics
Macrogenics MGNX
President And CEO
Holding Value $1.06M 248,000 shares
Last Trade
Feb 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.54M 248,000 shares
$18.30
$4.29
GlycoMimetics
GlycoMimetics GLYC
Director
Holding Value $577k 36,750 shares
Last Trade
Jun 01, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.03M 21,000 shares
$192.00
$15.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up